Ownership history in MORGAN STANLEY · 20 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in SENSEI BIOTHERAPEUTICS INC (SNSE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 10 | — | 0% | 0.00% | $107 | $10.67 |
| 2025 Q3 | UNCHANGED | 10 | — | 0% | 0.00% | $95 | $9.45 |
| 2025 Q2 | REDUCED | 10 | -9,209 | -99.9% | 0.00% | $86 | $8.58 |
| 2025 Q1 | UNCHANGED | 9,219 | — | 0% | 0.00% | $4K | $7.88 |
| 2024 Q4 | REDUCED | 9,219 | -3,000 | -24.6% | 0.00% | $5K | $9.80 |
| 2024 Q3 | UNCHANGED | 12,219 | — | 0% | 0.00% | $7K | $11.96 |
| 2024 Q2 | UNCHANGED | 12,219 | — | 0% | 0.00% | $8K | $12.40 |
| 2024 Q1 | ADDED | 12,219 | +12,000 | +5479.5% | 0.00% | $13K | $21.00 |
| 2023 Q4 | UNCHANGED | 219 | — | 0% | 0.00% | $151 | $13.84 |
| 2023 Q3 | UNCHANGED | 219 | — | 0% | 0.00% | $175 | $16.00 |
As of 2025 Q4 — sorted by position size